2023
DOI: 10.55563/clinexprheumatol/tep3k5
|View full text |Cite
|
Sign up to set email alerts
|

Goodpasture syndrome and anti-glomerular basement membrane disease

Abstract: Anti-glomerular basement membrane (anti-GBM) disease is a rare life-threatening small vessel vasculitis that typically affects the capillaries of kidneys and lungs, with most of patients developing rapidly progressive crescentic glomerulonephritis, and 40%-60% concomitant alveolar haemorrhage. It is caused by the deposition in alveolar and glomerular basement membrane of circulating autoantibodies directed against antigens intrinsic to the basement membrane. The exact mechanism that induces the formation of au… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 108 publications
0
7
0
Order By: Relevance
“…When the patient first presented to the ED, it was presumed that the elevated creatinine was the result of anti-GBM disease and presumptive treatment was started immediately due to the potential for alveolar hemorrhage and rapid progression to renal failure [ 6 ]. It is thought that the development of anti-GBM disease may be preceded by the production of autoantibodies triggered by an unknown stimulus such as pulmonary irritation or kidney injury, and prompt intervention is warranted for the optimization of patient outcomes [ 7 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…When the patient first presented to the ED, it was presumed that the elevated creatinine was the result of anti-GBM disease and presumptive treatment was started immediately due to the potential for alveolar hemorrhage and rapid progression to renal failure [ 6 ]. It is thought that the development of anti-GBM disease may be preceded by the production of autoantibodies triggered by an unknown stimulus such as pulmonary irritation or kidney injury, and prompt intervention is warranted for the optimization of patient outcomes [ 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…Anti-GBM disease, previously known as Goodpasture syndrome, is a life-threatening form of vasculitis in which IgG autoantibodies bind to the alpha-3 chain of type IV collagen in alveolar and glomerular basement membranes [ 6 , 7 ]. It typically presents with hemoptysis resulting from alveolar hemorrhage in conjunction with rapidly progressive glomerulonephritis that can result in renal failure if untreated [ 6 ]. Anti-GBM disease has previously been documented in conjunction with thrombocytopenia due to immune thrombocytopenia (ITP) [ 8 ] and with TTP [ 1 , 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…Hemoptysis is more common in younger patients with anti-GBM disease and concurrent severe renal and pulmonary symptoms at presentation. In contrast, patients over 50 years of age usually present with glomerulonephritis only and experience a less severe disease course [7].…”
Section: Goodpasture Syndromementioning
confidence: 99%
“…Goodpasture syndrome, or anti-glomerular basement membrane (anti-GBM) disease, manifests as an autoimmune condition in which antibodies target epitopes of an autoantigen found in collagen IV, a key component of kidney and lung basement membranes [7]. This article offers an updated overview of the pathogenetic mechanisms involved in the pulmonary manifestations of primary small-cell vasculitis, namely AAV and anti-GBM disease.…”
Section: Introductionmentioning
confidence: 99%
“…About 40%-60% of patients experience pulmonary inflammation and injury, with pulmonary hemorrhage being the initial symptom in severe cases. Failure to intervene promptly can result in respiratory distress and pose a life-threatening risk ( 23 25 ). It is reassuring to note that this percentage has been trending downward in recent studies (15%-35%) due to early detection and early intervention of the disease ( 3 , 4 , 26 ).…”
Section: Overview Of Anti-gbm Diseasementioning
confidence: 99%